Biology subjects

Thiele, I.

Publications and source records attributed to Thiele, I..

At least 19 recordsLinked to original sources

bioRxiv2025

StereoMapper: Clarifying Metabolite Identity Through Stereochemically Aware Relationship Assignment

Inaccuracies in metabolite cross-mapping frequently introduce errors into genome-scale metabolic models (GEMs). A key challenge lies in distinguishing truly identical metabolites from closely related structural variants, such as stereoisomers, across biochemical databases. StereoMapper addresses this issue by establishing stereochemically aware relationships that clarify metabolite identity. It operates entirely on structural information, using molecular structures to infer equivalence and define relationships. StereoMapper was implemented using RDKit (2025.3.3) and Open Babel-wheel (3.1.1.22) which provides the core functionality of the Open Babel software, and benchmarked across four curated control datasets to evaluate performance in relationship classification (enantiomer, diastereomer, stereo-resolution pairs, and protomer). The pipeline was subsequently applied to 1.3 million molecular structures from multiple metabolic databases to generate equivalent isomeric sets (groups of structures identified as equivalent by StereoMapper). These sets were compared against the human subset of MetaNetX, a context-aware reference, to assess concordance and investigate disagreements. On curated positive control sets containing only positive examples across multiple relationship classes, StereoMapper achieved mean precision, recall, and F1-scores of 92.6, 98.0, and 95.3, respectively; following optimisation, these improved to 98.9, 98.2, and 98.5. Application to the 1.3 million structures produced over 339,000 stereochemically defined relationships between molecular structures. Comparison with the human subset of MetaNetX assignments showed an overall grouping concordance of 93.5%. The remaining 6.5% of differences were mainly associated with protomer relationships (52.3%) and stereo-resolution pairs (37.4%), while 21.6% involved complex or ambiguous cases. Scientific contribution statementStereoMapper provides a stereochemically aware pipeline for metabolite relationship assignment that shows high performance across multiple benchmark datasets, resolving key ambiguities in metabolite identity and providing a complementary approach to existing context-aware frameworks. Its integration will enhance reaction-level cross-mapping and improve the accuracy of future GEM reconstructions.

systems biology↗

bioRxiv2025

Elucidating a potential role of the infant gut microbiome on the bioavailability of L-tyrosine in phenylketonuria

BackgroundPhenylketonuria (PKU) is an inherited metabolic disorder caused by phenylalanine hydroxylase (PAH) deficiency, leading to elevated L-phenylalanine and severe neurological damage if untreated. While phenylalanine-based biomarkers are diagnostic and phenylalanine levels correlate with disease severity, the clinical manifestations of PKU are heterogeneous. ResultsTo identify additional reliable, potentially novel biomarkers, we used germ-free sex-specific, organ-resolved infant whole-body metabolic models (infant-WBMs) to simulate PAH deficiency and predicted elevated L-phenylalanine and its derivatives, alongside reduced L-tyrosine fluxes, as the product of phenylalanine hydroxylation. To test the reliability of these predictions, we combined the infant-WBMs with gut microbiome models from 48 healthy infants. Upon integrating microbiome data, we found that microbial metabolism significantly increased L-tyrosine availability, obscuring its utility as a universal biomarker. In [~]23% of microbiome-PKU models, L-tyrosine fluxes remained low, indicating insufficient microbial compensation. These cases were enriched in Firmicutes and lacked specific Bifidobacterium and Escherichia strains linked to L-tyrosine biosynthesis via the pretyrosine pathway. Shadow price analysis identified microbial species critical for host L-tyrosine metabolism. However, some, such as Bifidobacterium dentium, also contributed to L-phenylalanine synthesis, potentially worsening the PKU phenotype. In contrast, L-phenylalanine, phenylpyruvate, and hydroxyphenylacetic acid remained reliably elevated across all models, validating their diagnostic relevance. ConclusionsOur study demonstrates that microbiome composition can modulate biomarker reliability in PKU, particularly for L-tyrosine. Integrating microbial metabolic models with whole-body physiology enables assessment of biomarker reliability and reveals subpopulations for whom secondary biomarkers or targeted probiotics may be beneficial. This approach offers a powerful framework for refining diagnostics and therapy monitoring in rare metabolic diseases and the development of possible targeted microbiome therapies.

systems biology↗

bioRxiv2025

Personalised whole-body modelling links gut microbiota to metabolic perturbations in Alzheimer's disease

The human gut microbiome has been linked to metabolic disturbances in Alzheimers disease (AD). However, the mechanisms by which gut microbes might influence metabolic dysfunction in AD remain poorly understood. Previously, we used constraint-based metabolic modelling to associate an increased risk of AD with altered production of microbiome-derived metabolites. In this study, we investigated whether these previous results can also be identified in AD patients. Therefore, we created personalised whole-body metabolic models from gut metagenomics samples from 34 AD dementia patients, 51 individuals with mild cognitive impairments, and 298 healthy controls. These in silico models were profiled to predict the metabolic influences of gut microbiomes on blood metabolites with previously reported alterations in AD. We found an increased capacity of AD host-microbiome co-metabolism to produce S-adenosyl-L-methionine, L-arginine, creatine, taurine, and formate in the blood of AD dementia patients and patients with mild cognitive impairments. The metabolic predictions were then mechanistically linked to gut microbial changes in AD. This analysis identified that increased relative abundances of Bacteroides uniformis and Bacteroides thetaiotamicron were key factors driving the predicted metabolic changes. Furthermore, the predicted altered microbial influences on blood metabolites were also associated with allelic variations in the APOE risk gene in healthy individuals, which confirmed our previous findings. In conclusion, we identified blood metabolites whose perturbations in AD may be influenced by gut microbiota and predicted the key microbial drivers for these metabolic influences. These findings may facilitate the development of microbiome-informed treatments of AD.

systems biology↗

bioRxiv2025

The MicroMap is a network visualisation resource for microbiome metabolism

The human microbiome plays a crucial role in metabolism and thereby influences health and disease. Constraint-based reconstruction and analysis (COBRA) has proven an attractive framework to generate mechanism-derived hypotheses along the nutrition-host-microbiome-disease axis within the computational systems biology community. Unlike for human, no large-scale visualisation resource for microbiome metabolism has been available to date. To address this gap, we created the MicroMap, a manually curated microbiome metabolic network visualisation, which captures the metabolic content of over a quarter million microbial genome-scale metabolic reconstructions. The MicroMap contains 5,064 unique reactions and 3,499 unique metabolites, including for 98 drugs. The MicroMap allows users to intuitively explore microbiome metabolism, inspect microbial metabolic capabilities, and visualise computational modelling results. Further, the MicroMap shall serve as an educational tool to make microbiome metabolism accessible to broader audiences beyond computational modellers. For example, we utilised the MicroMap to generate a comprehensive collection of 257,429 visualisations, corresponding to the entire scope of our current microbiome reconstruction resources, to enable users to visually compare and contrast the metabolic capabilities for diaerent microbes. The MicroMap seamlessly integrates with the Virtual Metabolic Human (VMH, www.vmh.life) and the COBRA Toolbox (opencobra.github.io), and is freely accessible at the MicroMap dataverse (https://dataverse.harvard.edu/dataverse/micromap), in addition to all the generated reconstruction visualisations.

systems biology↗

bioRxiv2024

fluxTrAM: Integration of tracer-based metabolomics data into atomically resolved genome-scale metabolic networks for metabolic flux analysis

Quantitative inference of intracellular reaction rates is essential for characterising metabolic phenotypes. The classical experimental method for measuring metabolic fluxes makes use of stable-isotope tracing of metabolites through the metabolic network, followed by mass spectrometry analysis. The most common 13C-based metabolic flux analysis requires multidisciplinary knowledge in analytical chemistry, cell biology, and mathematical modelling, as well as the use of multiple independent tools for handling mass spectrometry data. Besides, flux analysis is usually carried out within a small network to validate a specific biological hypothesis. To overcome interdisciplinary barriers and extend flux interpretation towards a genome-scale level, we developed fluxTrAM, a semi-automated pipeline for processing tracer- based metabolomics data and integrating it with atomically resolved genome-scale metabolic networks to enable flux predictions at genome-scale. fluxTrAM integrates different software packages inside and outside of the COBRA Toolbox v3.4 for the generation of metabolite structure and reaction databases for a genome-scale model, labelled mass spectrometry data processing into standardised mass isotopologue distribution data (MID), and metabolic flux analysis. To demonstrate the utility of this pipeline, we generated 13C-labeled metabolomics data on an in vitro human induced pluripotent stem cell (iPSC)-derived dopaminergic neuronal culture and processed 13C-labeled MID datasets. In parallel, we generated a cheminformatic database of standardised and context-specific metabolite structures, and atom-mapped reactions for a genome-scale dopaminergic neuronal metabolic model. MID data could be exported into established flux inference software for conventional flux inference on a core model scale. It could also be integrated into the atomically resolved metabolic model for flux inference at genome-scale using moiety fluxomics method. The core model flux solution and moiety flux solution were then compared to two additional flux solutions predicted via flux balance analysis and entropic flux balance analysis. The extensive computational flux analysis and comparison helped to better evaluate the obtained flux feasibility of the neuron-specific genome-scale model and suggested new tracer-based metabolomics experiments with novel labeling configurations, such as labelling a moiety within the thymidine metabolite. Overall, fluxTrAM enables the automation of labelled liquid chromatography (LC)-mass spectrometry (MS) data processing into MID datasets and atom mapping for any given genome-scale metabolic model. It contributes to the standardisation and high throughput of metabolic flux analysis at genome- scale.

systems biology↗

bioRxiv2024

Dynamic whole-body models for infant metabolism

1Comprehensive, sex-specific whole-body models (WBMs) accounting for organ-specific metabolism have been developed to allow for the simulation of adult and infant metabolism. These WBMs are evaluated daily, giving insights into metabolic flux changes that occur in one day of an infants or adults life. However, for medical applications, such as in metabolic diseases and their treatment, an evaluation and concentration predictions on a shorter time scale would be beneficial. Therefore, we developed a dynamic infant-WBM that couples metabolite dynamics in short time frames through physiology-based pharma-cokinetic models with the existing infant whole-body models. We then tailored the dynamic infant-WBM enabling the prediction of isovalerylcarnitine (C5), a clinical biomarker used for the inherited metabolic disease isovaleric aciduria (IVA). Our results show that, as expected, the predicted C5 concentrations exceeded the newborn screening thresholds during the time (36 - 72 hours) newborn screening blood samples are taken in the IVA models but not in models simulating healthy infants. We also demonstrate how the dynamic infant-WBMs can be used to test the effect changes in dietary intake have on the biomarker. Since the dynamic infant-WBMs were parametrised with literature-derived experimental or estimated values, we show how uncertainty quantification can be applied to quantify the parameter uncertainties. We found that the fractional unbound plasma needed to be estimated correctly, as this parameter strongly impacted C5 concentration predictions of the dynamic infant-WBMs. Overall, the dynamic infant-WBMs hold promise for personalised medicine, as it enables personalised biomarker concentration predictions of healthy and diseased infant metabolism in various time intervals.

systems biology↗

bioRxiv2024

Conserved moiety fluxomics

Fluxomics seeks to infer reaction fluxes at genome-scale by introducing isotopically labelled metabolites into a living system and measuring the enrichment of isotopic tracers in downstream metabolites. This approach has the potential to quantify fluxes at genome-scale but current approaches to infer steady-state metabolic reaction fluxes are either not tractable or not efficient at genome-scale as the corresponding computational models are high-dimensional, involve nonlinear constraints and lack mathematical guarantees of convergence to a global optimum. Herein, we introduce conserved moiety fluxomics, which is a novel, efficient, mathematically transparent, and computationally efficient method to infer metabolic reaction flux at genome-scale. We demonstrate how identification of the set of conserved moieties for a given metabolic network leads to a novel moiety graph decomposition of a stoichiometric matrix that can be used to linearly relate metabolic reaction fluxes to the rate at which conserved moieties transition between metabolites. This linear formulation avoids combinatorial explosion because the number of conserved moieties is bounded, most reactions correspond to a small number of conserved moiety transitions, it is sufficient to represent the flow of moieties that have the potential to be labelled, and it is sufficient to represent constraints from those isotopologues that are actually measured. A non-linear yet strictly convex objective is used to ensure that inferred fluxes satisfy energy conservation and the second law of thermodynamics. Numerical results demonstrate the computational tractability of conserved moiety fluxomics at genome-scale, given liquid chromatography-mass spectrometry derived stationary mass isotopologue distribution data from an in vitro dopaminergic neuronal culture fed 13C labelled glucose. Conserved moiety fluxomics unites the strengths of constraint-based modelling and metabolic flux analysis and has the potential to be further enhanced to enable inference of fluxes in whole-body metabolic models, including from non-stationary isotopic labelling data.

systems biology↗

bioRxiv2023

The Salmon Microbial Genome Atlas enables novel insights into bacteria-host interactions via functional mapping

The essential role of the gut microbiota for host health and nutrition is well established for many terrestrial animals, while its importance for fish and particularly Atlantic salmon is unclear. Here, we present the Salmon Microbial Genome Atlas (SMGA) originating from wild and farmed fish both in freshwater and seawater, and consisting of 211 high-quality bacterial genomes, recovered by cultivation (n=131) and gut metagenomics (n=80). Bacterial genomes were taxonomically assigned into 14 different orders, including 28 distinctive genera and 31 potentially novel species. Benchmarking the SMGA, we functionally characterized key populations in the salmon gut that were detected in vivo. This included the ability to degrade diet-derived fibers and release vitamins and other exo-metabolites with known beneficial effects, which were validated by in vitro cultivation and untargeted metabolomics. Together, the SMGA enables high resolution functional insight into salmon gut microbiota with relevance for salmon nutrition and health.

microbiology↗

bioRxiv2023

Personalised metabolic whole-body models for newborns and infants predict growth and biomarkers of inherited metabolic diseases

Extensive whole-body models (WBMs) accounting for organ-specific dynamics have been developed to simulate adult metabolism. However, there is currently a lack of models representing infant metabolism taking into consideration its special requirements in energy balance, nutrition, and growth. Here, we present a resource of organ-resolved, sex-specific, anatomically accurate models of newborn and infant metabolism, referred to as infant-whole-body models (infant-WBMs), spanning the first 180 days of life. These infant-WBMs were parameterised to represent the distinct metabolic characteristics of newborns and infants accurately. In particular, we adjusted the changes in organ weights, the energy requirements of brain development, heart function, and thermoregulation, as well as dietary requirements and energy requirements for physical activity. Subsequently, we validated the accuracy of the infant-WBMs by showing that the predicted neonatal and infant growth was consistent with the recommended growth by the World Health Organisation. We assessed the infant-WBMs reliability and capabilities for personalisation by simulating 10,000 newborn models, personalised with blood concentration measurements from newborn screening and birth weight. Moreover, we demonstrate that the models can accurately predict changes over time in known blood biomarkers in inherited metabolic diseases. By this, the infant-WBM resource can provide valuable insights into infant metabolism on an organ-resolved level and enable a holistic view of the metabolic processes occurring in infants, considering the unique energy and dietary requirements as well as growth patterns specific to this population. As such, the infant-WBM resource holds promise for personalised medicine, as the infant-WBMs could be a first step to digital metabolic twins for newborn and infant metabolism for personalised systematic simulations and treatment planning.

systems biology↗

bioRxiv2023

APOLLO: A genome-scale metabolic reconstruction resource of 247,092 diverse human microbes spanning multiple continents, age groups, and body sites

Computational modelling of microbiome metabolism has proved instrumental to catalyse our understanding of diet-host-microbiome-disease interactions through the interrogation of mechanistic, strain- and molecule-resolved metabolic models. We present APOLLO, a resource of 247,092 human microbial genome-scale metabolic reconstructions spanning 19 phyla and accounting for microbial genomes from 34 countries, all age groups, and five body sites. We explored the metabolic potential of the reconstructed strains and developed a machine learning classifier able to predict with high accuracy the taxonomic strain assignments. We also built 14,451 sample-specific microbial community models, which could be stratified by body site, age, and disease states. Finally, we predicted faecal metabolites enriched or depleted in gut microbiomes of people with Crohns disease, Parkinson disease, and undernourished children. APOLLO is compatible with the human whole-body models, and thus, provide unprecedented opportunities for systems-level modelling of personalised host-microbiome co-metabolism. APOLLO will be freely available under https://www.vmh.life/.

systems biology↗

bioRxiv2022

Longitudinal flux balance analyses of a patient with Crohn's disease highlight microbiome metabolic alterations

Inflammatory bowel diseases (IBD) are characterised by episodic inflammation of the gastrointestinal tract. Gut microbial dysbiosis characterises the pathoetiology, but its role remains understudied. We report the first use of constraint-based microbial community modelling on a single individual with IBD, covering seven dates over 16 months, enabling us to identify a number of time-correlated microbial species and metabolites. We find that the individuals dynamical microbial ecology in the disease state drives time-varying in silico overproduction, compared to healthy controls, of more than 24 biologically important metabolites, including oxygen, methane, thiamine, formaldehyde, trimethylamine N-oxide, folic acid, serotonin, histamine, and tryptamine. A number of these metabolites may yield new biomarkers of disease progression. The microbe-metabolite contribution analysis revealed that some genus Dialister species changed metabolic pathways according to the disease phases. At the first time point, characterised by the highest levels of blood and faecal inflammation biomarkers, they produced L-serine or formate. The production of the compounds, through a cascade effect, was mediated by the interaction with pathogenic Escherichia coli strains and Desulfovibrio piger. We integrated the microbial community metabolic models of each time point with a male whole-body, organ-resolved model of human metabolism to track the metabolic consequences of dysbiosis at different body sites. The presence of D. piger in the gut microbiome influenced the sulphur metabolism with a domino effect affecting the liver. These results underline the importance of tracking an individuals gut microbiome along a time course, creating a new analysis framework for self-quantified medicine. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=115 SRC="FIGDIR/small/520975v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@136ef4forg.highwire.dtl.DTLVardef@1993042org.highwire.dtl.DTLVardef@2f795forg.highwire.dtl.DTLVardef@c95a6d_HPS_FORMAT_FIGEXP M_FIG C_FIG

systems biology↗

bioRxiv2022

Systems biology illuminates alternative metabolic niches in the human gut microbiome

Human gut bacteria perform diverse metabolic functions with consequences for host health. The prevalent and disease-linked Actinobacterium Eggerthella lenta performs several unusual chemical transformations, but it does not metabolize sugars and its core growth strategy remains unclear. To obtain a comprehensive view of the metabolic network of E. lenta, we generated several complementary resources: defined culture media, metabolomics profiles of strain isolates, and a curated genome-scale metabolic reconstruction. Stable isotope-resolved metabolomics revealed that E. lenta uses acetate as a key carbon source while catabolizing arginine to generate ATP, traits which could be recapitulated in silico by our updated metabolic model. We compared these in vitro findings with metabolite shifts observed in E. lenta-colonized gnotobiotic mice, identifying shared signatures across environments and highlighting catabolism of the host signaling metabolite agmatine as an alternative energy pathway. Together, our results elucidate a distinctive metabolic niche filled by E. lenta in the gut ecosystem.

microbiology↗

bioRxiv2022

Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication

We aimed at investigating host-virus co-metabolism during SARS-CoV-2 infection. Therefore, we extended comprehensive sex-specific, whole-body organ resolved models of human metabolism with the necessary reactions to replicate SARS-CoV-2 in the lung as well as selected peripheral organs. Using this comprehensive host-virus model, we obtained the following key results: 1. The predicted maximal possible virus shedding rate was limited by isoleucine availability. 2. The supported initial viral load depended on the increase in CD4+ T-cells, consistent with the literature. 3. During viral infection, the whole-body metabolism changed including the blood metabolome, which agreed well with metabolomic studies from COVID-19 patients and healthy controls. 4. The virus shedding rate could be reduced by either inhibition of the guanylate kinase 1 or availability of amino acids, e.g., in the diet. 5. The virus variants achieved differed in their maximal possible virus shedding rates, which could be inversely linked to isoleucine occurrences in the sequences. Taken together, this study presents the metabolic crosstalk between host and virus and emphasis the role of amino acid metabolism during SARS-CoV-2 infection, in particular of isoleucine. As such, it provides an example of how computational modelling can complement more canonical approaches to gain insight into host-virus crosstalk and to identify potential therapeutic strategies.

systems biology↗

bioRxiv2021

XomicsToModel: Multiomics data integration and generation of thermodynamically consistent metabolic models

Constraint-based modelling can mechanistically simulate the behaviour of a biochemical system, permitting hypotheses generation, experimental design and interpretation of experimental data, with numerous applications, especially modelling of metabolism. Given a generic model, several methods have been developed to extract a context-specific, genome-scale metabolic model by incorporating information used to identify metabolic processes and gene activities in each context. However, existing model extraction algorithms are unable to ensure that a context-specific model is thermodynamically flux consistent. This protocol introduces XomicsToModel, a semiautomated pipeline that integrates bibliomic, transcriptomic, proteomic, and metabolomic data with a generic genome-scale metabolic reconstruction, or model, to extract a context-specific, genome-scale metabolic model that is stoichiometrically, thermodynamically and flux consistent. One of the key advantages of the XomicsToModel pipeline is its ability to seamlessly incorporate omics data into metabolic reconstructions, ensuring not only mechanistic accuracy but also physicochemical consistency. This functionality allows for more accurate metabolic simulations and predictions across different biological contexts, enhancing its utility in diverse research fields, including systems biology, drug development, and personalised medicine. The XomicsToModel pipeline is exemplified for extraction of a specific metabolic model from a generic metabolic model; it enables omics data integration and extraction of physicochemically consistent mechanistic models from any generic biochemical network. It can be implemented by anyone who has basic MATLAB programming skills and the fundamentals of constraint-based modelling. Key pointsXomicsToModel is a semi-automated pipeline that integrates bibliomic, transcriptomic, proteomic, and metabolomic data with a generic genome-scale metabolic reconstruction or model. It enables the seamless incorporation of multi-omics datasets into metabolic reconstructions, ensuring mechanistic accuracy and physicochemical consistency.

systems biology↗

bioRxiv2021

Mechanistic model-driven exometabolomic characterisation of human dopaminergic neuronal metabolism

Starting with a comprehensive generic reconstruction of human metabolism, we generated high-quality, constraint-based, genome-scale, cell-type and condition specific models of metabolism in human dopaminergic neurons, the cell type most vulnerable to degeneration in Parkinsons disease. They are a synthesis of extensive manual curation of the biochemical literature on neuronal metabolism, together with novel, quantitative, transcriptomic and targeted exometabolomic data from human stem cell-derived, midbrainspecific, dopaminergic neurons in vitro. Thermodynamic constraint-based modelling enabled qualitatively accurate and moderately quantitatively accurate prediction of dopaminergic neuronal metabolite exchange fluxes, including predicting the consequences of metabolic perturbations in a manner also consistent with literature on monogenic mitochondrial Parkinsons disease. These dopaminergic neurons models provide a foundation for a quantitative systems biochemistry approach to metabolic dysfunction in Parkinsons disease. Moreover, the plethora of novel mathematical and computational approaches required to develop them are generalisable to study any other disease associated with metabolic dysfunction.

systems biology↗

bioRxiv2021

Causal inference on microbiome-metabolome relations via in silico in vivo association pattern analyses

The effects of the microbiome on the hosts metabolism are core to understanding the role of the microbiome in health and disease. Herein, we develop the paradigm of in silico in vivo association pattern analyses, entailing a methodology to combine microbiome metabolome association studies with in silico constraint-based microbial community modelling. By dissecting confounding and causal paths, we show that in silico in vivo association pattern analyses allows for causal inference on microbiome-metabolome relations in observational data. Then, we demonstrate the feasibility and validity of our approach on a published multi-omics dataset (n=346), demonstrating causal microbiome-metabolite relations for 43 out of 53 metabolites from faeces. Finally, we utilise the identified in silico in vivo association pattern to estimate the microbial component of the faecal metabolome, revealing that the retrieved metabolite prediction scores correlate with the measured metabolite concentrations, and they also reflect the multivariate structure of the faecal metabolome. Concluding, we integrate with hypothesis free screening association studies and knowledge-based in silico modelling two major paradigms of systems biology, generating a promising new paradigm for causal inference in metabolic host-microbe interactions.

systems biology↗

bioRxiv2020

AGORA2: Large scale reconstruction of the microbiome highlights wide-spread drug-metabolising capacities.

The human microbiome influences the efficacy and safety of a wide variety of commonly prescribed drugs, yet comprehensive systems-level approaches to interrogate drug-microbiome interactions are lacking. Here, we present a computational resource of human microbial genome-scale reconstructions, deemed AGORA2, which accounts for 7,206 strains, includes microbial drug degradation and biotransformation, and was extensively curated based on comparative genomics and literature searches. AGORA2 serves as a knowledge base for the human microbiome and as a metabolic modelling resource. We demonstrate the latter by mechanistically modelling microbial drug metabolism capabilities in single strains and pairwise models. Moreover, we predict the individual-specific drug conversion potential in a cohort of 616 colorectal cancer patients and controls. This analysis reveals that some drug activation capabilities are present in only a subset of individuals, moreover, drug conversion potential correlate with clinical parameters. Thus, AGORA2 paves the way towards personalised, predictive analysis of host-drug-microbiome interactions.

systems biology↗

bioRxiv2020

Integration of constraint-based modeling with fecal metabolomics reveals large deleterious effects of Fusobacteria species on community butyrate production

Integrating constraint-based community modelling with population statistics, we introduce new theoretical concepts for interrogating the metabolic functions of the microbiome, applying them to a public metagenomic dataset consisting of 365 colorectal cancer cases (CRC) and 251 healthy controls. We found that 1) glutarate production capability was significantly enriched in CRC microbiomes and mechanistically linked to lysine fermentation in Fusobacteria species, 2) acetate and butyrate production potentials were lowered in CRC, 3) Fusobacteria presence had large negative ecological effects on community butyrate production in CRC and healthy controls. Validating the model predictions against faecal metabolomics, our in silico frameworks correctly predicted in vivo species metabolite correlations with high accuracy. In conclusion, highlighting the value of combining statistical association studies with in silico modelling, this study delivers insights on the metabolic role of Fusobacteria in the gut, while providing a proof of concept for the validity of constraint-based community modelling.

systems biology↗